BRPI0822069B8 - método para preparação de um extrato de fruta de cardo leiteiro - Google Patents
método para preparação de um extrato de fruta de cardo leiteiroInfo
- Publication number
- BRPI0822069B8 BRPI0822069B8 BRPI0822069A BRPI0822069A BRPI0822069B8 BR PI0822069 B8 BRPI0822069 B8 BR PI0822069B8 BR PI0822069 A BRPI0822069 A BR PI0822069A BR PI0822069 A BRPI0822069 A BR PI0822069A BR PI0822069 B8 BRPI0822069 B8 BR PI0822069B8
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- milk thistle
- fruit extract
- extract
- thistle fruit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007063115 | 2007-12-23 | ||
DE102007063115.6 | 2007-12-23 | ||
DE102008039271A DE102008039271A1 (de) | 2007-12-23 | 2008-08-23 | Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung |
DE102008039271.5 | 2008-08-23 | ||
PCT/DE2008/002117 WO2009080006A2 (de) | 2007-12-23 | 2008-12-23 | Neuer mariendistelextrakt, verfahren zur herstellung und verwendung |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0822069A2 BRPI0822069A2 (pt) | 2015-06-23 |
BRPI0822069B1 BRPI0822069B1 (pt) | 2019-10-08 |
BRPI0822069B8 true BRPI0822069B8 (pt) | 2021-05-25 |
Family
ID=40690102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0822069A BRPI0822069B8 (pt) | 2007-12-23 | 2008-12-23 | método para preparação de um extrato de fruta de cardo leiteiro |
Country Status (20)
Country | Link |
---|---|
US (1) | US20110027396A1 (ja) |
EP (2) | EP2222320B1 (ja) |
JP (2) | JP5442632B2 (ja) |
KR (2) | KR101607445B1 (ja) |
CN (2) | CN101925360A (ja) |
AU (1) | AU2008340922B2 (ja) |
BR (1) | BRPI0822069B8 (ja) |
CA (2) | CA2709947C (ja) |
CY (1) | CY1115081T1 (ja) |
DE (1) | DE102008039271A1 (ja) |
DK (1) | DK2222320T3 (ja) |
ES (1) | ES2438003T3 (ja) |
HK (1) | HK1203352A1 (ja) |
HR (1) | HRP20131165T1 (ja) |
MX (1) | MX2010006982A (ja) |
PL (1) | PL2222320T3 (ja) |
PT (1) | PT2222320E (ja) |
RU (1) | RU2489161C2 (ja) |
SI (1) | SI2222320T1 (ja) |
WO (1) | WO2009080006A2 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2761656C (en) * | 2009-05-14 | 2017-02-07 | Lucio Claudio Rovati | Amorphous silibinin for the treatment of viral hepatitis |
CN102225085B (zh) * | 2011-06-20 | 2012-09-05 | 黑龙江大学 | 一种从水飞蓟秸秆中提取水飞蓟总黄酮的方法 |
KR101316806B1 (ko) * | 2011-08-02 | 2013-10-10 | (주)이뮤노텍 | 글루타치온과 실리마린을 유효성분으로 함유하는 항산화 및 간보호용 조성물 |
KR101655396B1 (ko) * | 2013-08-06 | 2016-09-08 | 에스케이바이오랜드 주식회사 | 수용성 밀크씨슬 추출물 및 이의 제조방법 |
JP2015113332A (ja) * | 2013-12-16 | 2015-06-22 | 花王株式会社 | 生薬粉体 |
CN104744447B (zh) * | 2013-12-31 | 2017-12-26 | 天士力制药集团股份有限公司 | 水飞蓟宾迷迭香酸酯及其制备方法和用途 |
CN104651037A (zh) * | 2014-01-17 | 2015-05-27 | 吴长军 | 一种亚临界流体萃取水飞蓟籽仁中油脂和蛋白的方法 |
CN105622594B (zh) * | 2016-03-17 | 2019-05-17 | 江苏中兴药业有限公司 | 一种高纯度水飞蓟素的制备方法 |
ES2706008B8 (es) * | 2017-09-22 | 2021-07-12 | Euromed S A | Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida |
KR102242002B1 (ko) | 2019-02-21 | 2021-04-19 | 주식회사 노바케이메드 | 동충하초균사체로 고상발효된 홍삼 추출물을 유효성분으로 함유하는 지방간 질환 예방 또는 치료용 조성물 |
CN111518090B (zh) * | 2020-05-12 | 2021-08-10 | 沈阳药科大学 | 黄烷黄酮衍生物及其制备方法和用途 |
KR102669644B1 (ko) * | 2023-06-27 | 2024-05-27 | 한국자연한방 주식회사 | 실리마린 생체이용률이 증대된 밀크씨슬 추출물을 포함하는 지방간 개선, 예방 또는 치료용 조성물 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1767666C3 (de) | 1968-06-01 | 1986-07-31 | Dr. Madaus & Co, 5000 Koeln | Pharmazeutische Zubereitung gegen Lebererkrankungen |
DE1923982C3 (de) | 1969-05-10 | 1978-07-13 | Hoechst Ag, 6000 Frankfurt | Flammfestmachen von Polyurethanschaumstoffen |
DE2020407A1 (de) | 1970-04-27 | 1971-11-11 | Bernhard Dr Janiak | Technisches Verfahren zur Isolierung von Silimarin |
FR2181188A5 (en) | 1972-04-20 | 1973-11-30 | Dott Inverni Della Beffa | Polyhydroxyphenylchromones - by solvent extn of non-defatted fruit of Silybum marianum |
US4061765A (en) * | 1973-01-19 | 1977-12-06 | Dr. Madaus & Co. | Polyhydroxyphenylchromanone salts and therapeutic composition |
DD112261A1 (ja) * | 1974-06-18 | 1975-04-05 | ||
DE2914330A1 (de) | 1979-04-09 | 1980-10-30 | Madaus & Co Dr | Verfahren zur gewinnung von silymarin aus pflanzen |
CH646695A5 (en) * | 1980-10-06 | 1984-12-14 | Madaus & Co Dr | Method of obtaining silymarin from plants |
DE3225688A1 (de) * | 1982-07-09 | 1984-01-12 | Suschnik Matthias Dr | Verfahren zur gewinnung von silymarin aus silybum marianum |
IT1241673B (it) | 1989-10-09 | 1994-01-27 | Istituto Biochimico Italiano | Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono. |
DE19501266A1 (de) | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
KR0161349B1 (ko) | 1995-01-20 | 1998-11-16 | 무라따 야스따까 | 압전 자기 조성물 |
RU2102999C1 (ru) * | 1996-07-10 | 1998-01-27 | Куркин Владимир Александрович | Способ получения экстракта расторопши пятнистой |
DE19744459A1 (de) * | 1997-10-08 | 1999-04-15 | Schwabe Willmar Gmbh & Co | Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen |
IN192343B (ja) * | 2000-05-26 | 2004-04-10 | Ranbaxy Lab Ltd | |
CZ292832B6 (cs) * | 2001-08-30 | 2003-12-17 | Ivax Pharmaceuticals S.R.O. | Způsob přípravy silymarinu se zvýšenou rozpustností |
JP2003135023A (ja) | 2001-10-30 | 2003-05-13 | Os Kogyo Kk | 健康食品 |
US7238373B2 (en) * | 2003-04-04 | 2007-07-03 | Nutritox Llc | Nutritional supplement |
-
2008
- 2008-08-23 DE DE102008039271A patent/DE102008039271A1/de not_active Withdrawn
- 2008-12-23 CA CA2709947A patent/CA2709947C/en active Active
- 2008-12-23 KR KR1020157006607A patent/KR101607445B1/ko active IP Right Grant
- 2008-12-23 JP JP2010538335A patent/JP5442632B2/ja active Active
- 2008-12-23 PL PL08865199T patent/PL2222320T3/pl unknown
- 2008-12-23 RU RU2010130855/15A patent/RU2489161C2/ru active
- 2008-12-23 EP EP08865199.7A patent/EP2222320B1/de active Active
- 2008-12-23 PT PT88651997T patent/PT2222320E/pt unknown
- 2008-12-23 DK DK08865199.7T patent/DK2222320T3/da active
- 2008-12-23 ES ES08865199.7T patent/ES2438003T3/es active Active
- 2008-12-23 CN CN2008801254794A patent/CN101925360A/zh active Pending
- 2008-12-23 EP EP12195762A patent/EP2567703A3/de not_active Withdrawn
- 2008-12-23 BR BRPI0822069A patent/BRPI0822069B8/pt active IP Right Grant
- 2008-12-23 WO PCT/DE2008/002117 patent/WO2009080006A2/de active Application Filing
- 2008-12-23 MX MX2010006982A patent/MX2010006982A/es active IP Right Grant
- 2008-12-23 CN CN201410378585.0A patent/CN104189043A/zh active Pending
- 2008-12-23 KR KR1020107015846A patent/KR101541938B1/ko active IP Right Grant
- 2008-12-23 US US12/810,178 patent/US20110027396A1/en not_active Abandoned
- 2008-12-23 AU AU2008340922A patent/AU2008340922B2/en active Active
- 2008-12-23 SI SI200831118T patent/SI2222320T1/sl unknown
- 2008-12-23 CA CA2922846A patent/CA2922846A1/en not_active Abandoned
-
2011
- 2011-01-26 HK HK15103460.8A patent/HK1203352A1/xx unknown
-
2013
- 2013-12-06 HR HRP20131165AT patent/HRP20131165T1/hr unknown
- 2013-12-13 CY CY20131101145T patent/CY1115081T1/el unknown
- 2013-12-18 JP JP2013260758A patent/JP2014074051A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0822069B8 (pt) | método para preparação de um extrato de fruta de cardo leiteiro | |
BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
PL3517539T3 (pl) | Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II | |
BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
CO6280490A2 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
MX2013008850A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
ECSP13012379A (es) | Pirimidinas y triazinas condensadas y su uso | |
IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
AP2012006135A0 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof. | |
UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
BRPI0812851A2 (pt) | Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto | |
BR112014008294A2 (pt) | anticorpo anti c-met e usos do mesmo | |
EA033067B1 (ru) | Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения | |
WO2014049447A3 (en) | A whole, leech saliva extract | |
ES2542042R1 (es) | Composiciones farmacéuticas y uso para preparar un medicamento destinado al tratamiento de la obesidad, los trastornos metabólicos relacionados y la adicción a sustancias psicoactivas | |
BR112013033078A2 (pt) | partícula, composição farmacêutica, conjunto para o tratamento do câncer e método para o tratamento do câncer em um paciente | |
BR112013031712A2 (pt) | composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença. | |
ZA201203281B (en) | Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals | |
BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
ES2425315R1 (es) | Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria | |
WO2012125981A3 (en) | Raf kinase inhibitors | |
BR112015006656A8 (pt) | composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |